Clinical Trials Browser

Phase 1 × Neoplasms × Craniotomy × Clear all

NCT02507583 2025-05-07

Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma

Phase 1 Completed

Brain Neoplasms, Glioma, Neoplasms